Kevin L. Carter

Biomarker Changes in Alzheimer Disease
12/17/2012
Alzheimer disease (AD) is the most common cause of dementia and currently affects about 5 million Americans. By 2050, this number is expected to increase to 13 million.
Alzheimer disease (AD) is the most common cause of dementia and currently affects about 5 million Americans. By 2050, this number is expected to increase to 13 million.
Alzheimer disease (AD) is the...
12/17/2012
First Report Managed Care
Department
Adult Vaccination Strategies for Invasive Pneumococcal Disease
06/19/2012
Although the 23-valent pneumococcal polysaccharide vaccine (PPSV23) has been recommended for prevention of invasive pneumococcal disease (IPD) in adults since 1983, there have been no conclusive assessments of its ability to prevent...
Although the 23-valent pneumococcal polysaccharide vaccine (PPSV23) has been recommended for prevention of invasive pneumococcal disease (IPD) in adults since 1983, there have been no conclusive assessments of its ability to prevent...
Although the 23-valent...
06/19/2012
First Report Managed Care
Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer
08/16/2012
The administration of radioiodine (131I) has traditionally been part of therapy to patients with thyroid cancer after thyroidectomy; however, it is unclear whether this administration provides any benefit after a complete surgical resection....
The administration of radioiodine (131I) has traditionally been part of therapy to patients with thyroid cancer after thyroidectomy; however, it is unclear whether this administration provides any benefit after a complete surgical resection....
The administration of...
08/16/2012
First Report Managed Care
Conference Insider
Evaluating a Program to Reduce MRSA Infections after Cardiothoracic Surgery
03/21/2011
Although the incidence of surgical site infections (SSIs) after cardiothoracic (CT) surgery is relatively low, these infections can carry significant morbidity and mortality and can incur substantial costs. The overall incidence of serious...
Although the incidence of surgical site infections (SSIs) after cardiothoracic (CT) surgery is relatively low, these infections can carry significant morbidity and mortality and can incur substantial costs. The overall incidence of serious...
Although the incidence of...
03/21/2011
First Report Managed Care
Targeted Therapies for Cancer
11/21/2013
The treatment of cancer is evolving from a largely reactive, empirical approach to a proactive one in which genomic information is used to improve diagnostic accuracy, guide therapeutic choices, and improve patient outcomes. 
The treatment of cancer is evolving from a largely reactive, empirical approach to a proactive one in which genomic information is used to improve diagnostic accuracy, guide therapeutic choices, and improve patient outcomes. 
The treatment of cancer is...
11/21/2013
First Report Managed Care
Development of Electronic Prior Authorization Has Reached an Inflection Point
05/24/2012
San Francisco—“With the possibility of radical changes in the way pharmacy benefits are administered and delivered, the development of electronic prior authorization (ePA) has reached an inflection point, and the industry needs to work...
San Francisco—“With the possibility of radical changes in the way pharmacy benefits are administered and delivered, the development of electronic prior authorization (ePA) has reached an inflection point, and the industry needs to work...
San Francisco—“With the...
05/24/2012
First Report Managed Care
Inhibition of HIV-1 Disease Progression
12/17/2012
Two important human lentiviruses have been described: (1) pandemic HIV type 1 (HIV-1), and (2) HIV type 2 (HIV-2), which is mainly confined to West Africa. Both viruses have similar transmission routes, cellular targets, and AIDS-defining...
Two important human lentiviruses have been described: (1) pandemic HIV type 1 (HIV-1), and (2) HIV type 2 (HIV-2), which is mainly confined to West Africa. Both viruses have similar transmission routes, cellular targets, and AIDS-defining...
Two important human lentiviruses...
12/17/2012
First Report Managed Care
Department
Randomized Controlled Trials of Biologics for Rheumatoid Arthritis
04/26/2012
Disease-modifying antirheumatic drugs for rheumatoid arthritis have been considered effective treatments that can reduce or prevent joint damage.
Disease-modifying antirheumatic drugs for rheumatoid arthritis have been considered effective treatments that can reduce or prevent joint damage.
Disease-modifying antirheumatic...
04/26/2012
First Report Managed Care
Patterns of Antiamyloid-β Antibodies in Typical and Atypical Alzheimer Disease
08/16/2012
A major feature of Alzheimer disease (AD) is the deposition of brain amyloid-β (Aβ) peptide. IgG antibodies directed to Aβ naturally occur in the elderly, and their serum and cerebrospinal fluid levels may be significantly altered in the...
A major feature of Alzheimer disease (AD) is the deposition of brain amyloid-β (Aβ) peptide. IgG antibodies directed to Aβ naturally occur in the elderly, and their serum and cerebrospinal fluid levels may be significantly altered in the...
A major feature of Alzheimer...
08/16/2012
First Report Managed Care
Conference Insider
Place-of-Service Management for Infusible Drugs
05/24/2012
San Francisco—Infliximab, a monoclonal antibody against tumor necrosis factor alpha (TNFα), is used to treat autoimmune conditions such as psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and...
San Francisco—Infliximab, a monoclonal antibody against tumor necrosis factor alpha (TNFα), is used to treat autoimmune conditions such as psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and...
San Francisco—Infliximab, a...
05/24/2012
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use